Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
10.71
-0.03 (-0.28%)
At close: May 12, 2025, 4:00 PM
10.60
-0.11 (-1.03%)
After-hours: May 12, 2025, 4:20 PM EDT
Haleon Revenue
In the year 2024, Haleon had annual revenue of 11.23B GBP, down -0.61%. Haleon had revenue of 2.76B in the quarter ending December 31, 2024, a decrease of -0.25%.
Revenue (ttm)
11.23B GBP
Revenue Growth
-0.61%
P/S Ratio
3.42
Revenue / Employee
457,351 GBP
Employees
24,561
Market Cap
48.11B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
HLN News
- 10 days ago - Haleon plc (HLN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Brightseed and Haleon Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation - Business Wire
- 11 days ago - Consumer healthcare group Haleon raises medium-term profit forecast - Reuters
- 12 days ago - Haleon reports lower first-quarter revenue hurt by a weaker flu season - Reuters
- 27 days ago - UK's Haleon takes full control of Chinese consumer healthcare venture - Reuters
- 6 weeks ago - Haleon: A Defensive Play That Makes Sense Amidst The Stock Market Sell-Off - Seeking Alpha
- 7 weeks ago - Pfizer sells entire Haleon stake for $3.24 billion - Reuters
- 7 weeks ago - Pfizer to dispose of entire Haleon stake - Reuters